	Actif À Court Terme		Date
AbbVie	USD 28.54B	722M	2025-09
Acadia Pharmaceuticals	USD 1.08B	115.87M	2025-09
Akebia Therapeutics	USD 258.34M	23.68M	2025-09
ALKERMES	USD 1.74B	106.38M	2025-09
Alnylam Pharmaceuticals	USD 3.95B	309.11M	2025-09
Amarin	USD 628.33M	21.52M	2025-09
Amgen	USD 29.06B	1.17B	2025-12
Baxter International	USD 6.93B	184M	2025-09
Biogen	USD 8.97B	37.5M	2025-12
BioMarin Pharmaceutical	USD 3.85B	49.21M	2025-09
Bristol-Myers Squibb	USD 35.63B	2.41B	2025-09
Coherus Biosciences	USD 460.96M	80.75M	2025-09
Eli Lilly	USD 62.07B	12.22B	2025-09
Fujifilm	JPY 1.72T	120.76B	2025-12
Gilead Sciences	USD 18.84B	4.12B	2025-09
Ironwood Pharmaceuticals	USD 273.84M	82.09M	2025-09
Merck	USD 47.56B	10.49B	2025-09
Myriad Genetics	USD 344.8M	60.5M	2025-09
Pacira	USD 562.75M	182.86M	2025-09
Perrigo	USD 2.88B	264.2M	2025-09
Pfizer	USD 46.92B	3.22B	2025-09
PTC Therapeutics	USD 2.01B	265.07M	2025-09
Regeneron Pharmaceuticals	USD 18.02B	41.2M	2025-12
Sarepta Therapeutics	USD 2.72B	65.32M	2025-09
Teva Pharmaceutical Industries	USD 13.95B	1.21B	2025-12
Vertex Pharmaceuticals	USD 10.57B	141.7M	2025-09
Xencor	USD 518.44M	5.29M	2025-09
Zoetis	USD 6.58B	660M	2025-09

Coherus Biosciences Actif À Court Terme - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.